三达膜(688101) - 2022 Q1 - 季度财报

Financial Performance - Operating revenue for Q1 2022 was CNY 164,304,322.88, an increase of 2.78% compared to the same period last year[3] - Net profit attributable to shareholders was CNY 58,181,871.82, a decrease of 7.99% year-on-year[3] - Basic earnings per share for the period was CNY 0.17, down 8.28% from the previous year[4] - The weighted average return on equity was 1.68%, a decrease of 0.22 percentage points[4] - Net profit for Q1 2022 was ¥59.48 million, a decrease of 6.3% compared to ¥63.79 million in Q1 2021[20] - The company reported a total profit of ¥65.52 million in Q1 2022, down from ¥70.61 million in Q1 2021[20] Research and Development - R&D investment totaled CNY 10,169,998.91, representing 6.19% of operating revenue, an increase of 1.19 percentage points[4] - Research and development expenses rose to ¥10.17 million in Q1 2022, up 27.3% from ¥7.99 million in Q1 2021[19] Cash Flow and Liquidity - Net cash flow from operating activities was CNY 14,571,468.67, with a significant increase attributed to the commencement of several large-scale membrane technology projects[8] - Cash flow from operating activities generated a net inflow of ¥14.57 million in Q1 2022, compared to a net outflow of ¥33.74 million in Q1 2021[22] - Cash and cash equivalents were reported at CNY 824,765,526.69, down from CNY 1,231,756,309.30, representing a decrease of approximately 33%[15] - Cash and cash equivalents at the end of Q1 2022 were ¥812.91 million, down from ¥916.02 million at the end of Q1 2021[22] Assets and Liabilities - Total assets at the end of the period were CNY 4,917,615,979.17, an increase of 1.30% from the end of the previous year[4] - The company's total current assets reached CNY 2,918,169,336.98, compared to CNY 2,865,673,755.51 in the previous year, indicating an increase of about 1.8%[16] - The company's total liabilities stood at CNY 1,379,494,042.27, slightly up from CNY 1,375,985,512.15, showing a marginal increase of about 0.1%[17] - The total equity attributable to shareholders was CNY 3,492,640,608.52, an increase from CNY 3,434,458,736.70, reflecting a growth of approximately 1.7%[17] - The company's inventory increased to CNY 677,673,899.73 from CNY 591,767,853.70, marking a rise of about 14.5%[16] - The accounts receivable decreased slightly to CNY 559,366,463.44 from CNY 570,034,482.96, indicating a decline of approximately 1.8%[15] - The company’s non-current assets totaled CNY 1,999,446,642.19, a slight increase from CNY 1,988,958,222.42, reflecting a growth of about 0.5%[16] - The company’s total liabilities and equity amounted to CNY 4,917,615,979.17, consistent with the total assets reported[18] Shareholder Information - The total number of ordinary shareholders at the end of the period was 14,331[10] - The largest shareholder, Sanda Membrane Technology (Singapore) Co., Ltd., held 43.36% of the shares[11] Financial Standards and Governance - The company has implemented new accounting standards starting from 2022, affecting the financial statements from the beginning of the year[23] - The board of directors held a meeting on April 28, 2022, to discuss the quarterly report[24]